Shinryo Fund Invests in HerLifeLab, Supporting Women with Menopausal Symptoms
NQ Score
0/100
N1 Content Completeness
7
AI Summary (NQ-processed)
The Shinryo Fund, operated by Fourseeds Co., Ltd., has invested in HerLifeLab Inc., a startup that provides services to support women suffering from menopausal symptoms. The investment amount is undisclosed. HerLifeLab aims to create a society where working women can continue to work long and fulfilling lives by leveraging the expertise of its CEO, a medical doctor, and a collaborating gynecologist. The Shinryo Fund will support HerLifeLab's expansion into Asia and collaboration with Okinawa's tourism industry.
AI Analysis
Frequently Asked Questions
- Q: What is the amount of this investment?
- A: The investment amount is not disclosed in the article.
- Q: What is HerLifeLab's main service?
- A: It provides services to support women suffering from menopausal symptoms, but the specific service name is not mentioned in the article.
- Q: What are the investment targets of the Shinryo Fund?
- A: It primarily invests in and supports seed-stage startups.